Leap Therapeutics logo
Leap Therapeutics
LPTX | NASDAQ
Chart Builder DCF Calculator
$0.77
-$0.02 (-3.10%)
At close: Apr 01, 2026, 09:30 AM ET

Leap Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
4.82M -67.56M -81.41M -54.6M -40.59M -27.51M
– 5K 15K 16K 29K 34K
4.9M 5.5M 5.13M 5.18M 3.48M 2.62M
1.72M 388K 497K 358K -2.89M -1.11M
-50.19M 457K 30.01M 1.01M 527K -104K
5.12M – – – 379K –
-8.56M 1.29M 2.51M -651K 1.01M -990K
-43.9M -60.3M -43.75M -49.04M -35.16M -25.96M
– – – – – –
– – 50.36M – – –
– – – – – –
– – – – – –
– – -1.39M – – 25K
-97M – 48.97M – – 25K
-440K – – – – –
– – -1K – – –
– – – – – –
– -2.82M -1K -210K 813K -1.51M
107.65M 37.18M -30K -210K 98.04M 74M
-33.21M -23.39M 5.14M -49.42M 62.85M 48.18M
-43.9M -60.3M -43.75M -49.04M -35.16M -25.96M
-48.8M -65.8M -48.88M -54.22M -38.64M -28.57M
– – – – – –
– – – – – –
-43.9M -60.3M -43.75M -49.04M -35.16M -25.96M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.